EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL)

Rita de Cássia Cavaglieri, Luciana Nardinelli, Melissa Rijken, Ana Silvia Gouveia-Lima, Peter J M Valk, Fabíola Traina, Eduardo M Rego

Clinical Lymphoma Myeloma and Leukemia · 2026-06 · 26 (6) · 351-356.e1

DOI: 10.1016/j.clml.2026.03.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-06. Verfasst von Rita de Cássia Cavaglieri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation-31 (LIM-31), Department of Internal Medicine, Division of Hematology, Faculty of Medicine, University of São Paul…. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Society of Hematology, ASH Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Next-generation sequencing (NGS) has transformed the diagnostic and prognostic landscape of acute myeloid leukemia (AML) by enabling the simultaneous detection of multiple clinically relevant mutations. However, access to this technology remains limited in many Latin American countries due to economic and infrastructural constraints. This study reports the implementation and validation of an NGS workflow for AML molecular profiling within the International Consortium on Acute Leukemias (ICAL), emphasizing feasibility and reproducibility across reference laboratories in Brazil. iSeq100 sequencers (Illumina) were donated to ICAL centers. Laboratory personnel received training through the American Society of Hematology's Visitor Training Program at Erasmus MC (Rotterdam). Genomic DNA from 15 AML patients enrolled in the ICAL-2015 study was analyzed using a custom amplicon-based panel targeting FLT3, NPM1, IDH1, IDH2, ASXL1, CEBPA, TP53, and RUNX1. Results were compared between the 2 Brazilian laboratories, a European reference laboratory, and conventional single-gene testing. NGS demonstrated positive interlaboratory concordance for variant allele frequencies (Pearson r = 0.72). Concordance between NGS and PCR-based methods reached 77%, with discordant cases involving FLT3-ITD detection and the assessment of ASXL1 mutations. Mutation frequencies were consistent with those reported in European and North American cohorts. The present study demonstrates that simplified NGS workflows can be successfully established and quality-controlled in resource-constrained settings through international collaboration, training, and standardized protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

High-Throughput Nucleotide SequencingLeukemia, Myeloid, AcuteHumansNucleophosminMutationBrazilResource-Limited SettingsFemaleMaleReproducibility of Results

Stichwörter der Autor:innen

Acute myeloid leukemiaBrazilGenomeMutationNetworking

Substanzen

NucleophosminNPM1 protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Investigation-31 (LIM-31), Department of Internal Medicine, Division of Hematology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.
  • Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Medical Imaging, Hematology, and Oncology, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.
  • Laboratory of Medical Investigation-31 (LIM-31), Department of Internal Medicine, Division of Hematology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil. Electronic address: eduardo.rego@fm.usp.br.

Förderung

  • American Society of Hematology
  • ASH Foundation

Zitieren

APA

de Cássia Cavaglieri, R., Nardinelli, L., Rijken, M., Gouveia-Lima, A. S., Valk, P. J. M., Traina, F., & Rego, E. M. (2026). SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL). Clinical Lymphoma Myeloma and Leukemia, 26(6), 351-356.e1. https://doi.org/10.1016/j.clml.2026.03.008

Vancouver

de Cássia Cavaglieri R, Nardinelli L, Rijken M, Gouveia-Lima AS, Valk PJM, Traina F, et al. SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL). Clinical Lymphoma Myeloma and Leukemia. 2026;26(6):351-356.e1. doi:10.1016/j.clml.2026.03.008

BibTeX
@article{deCssiaCavaglieri2026,
  author = {de Cássia Cavaglieri, Rita and Nardinelli, Luciana and Rijken, Melissa and Gouveia-Lima, Ana Silvia and Valk, Peter J M and Traina, Fabíola and Rego, Eduardo M},
  title = {SOHO State of the Art Updates and Next Questions | Implementing Next-Generation Sequencing (NGS) in Resource-Constrained Settings: The Experience of the International Consortium on Acute Leukemias (ICAL)},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {6},
  pages = {351--356.e1},
  doi = {10.1016/j.clml.2026.03.008}
}
Kostenlos starten →